S4 E24, Sarah DiSalvatore, Fractional SVP of Clinical Operations & Biotech Executive

Leading with Purpose in Rare Disease with Sarah DiSalvatoreIn this episode of She Leads Biotech, I’m joined by Sarah DiSalvatore, Fractional SVP of Clinical Operations & Biotech Executive, for a conversation about leadership, rare disease, and the realities of bringing innovative therapies to patients.Sarah shares her journey from bench research to executive leadership, why quality and compliance are fundamental to successful clinical development, and how fractional leadership is helping early-stage biotech companies build smarter and more efficiently.We also discuss the deeply personal experience of becoming a rare disease parent, and how that has transformed the way Sarah approaches patient advocacy, programme development, and the importance of building centres of excellence for underserved communities.A thoughtful conversation about resilience, strategy, and keeping patients at the centre of every decision.Chapters00:00 Introduction02:00 A Childhood Dream of Medicine06:00 From Bench Research to Clinical Operations11:00 Why Quality and Compliance Matter16:00 Growing into Leadership20:00 The Rise of Fractional Executives25:00 Becoming a Rare Disease Parent30:00 How Personal Experience Changed Clinical Development34:00 Building Centres of Excellence for Rare Diseases38:00 The Future of Clinical Operations42:00 Advice for Parents, Caregivers & Leaders#SheLeadsBiotech #RareDisease #ClinicalOperations #BiotechLeadership #GeneTherapy #WomenInBiotech #CNAUSAExecutiveSearch